Medicover AB Statistics
Total Valuation
Medicover AB has a market cap or net worth of SEK 36.18 billion. The enterprise value is 48.75 billion.
Market Cap | 36.18B |
Enterprise Value | 48.75B |
Important Dates
The last earnings date was Tuesday, April 29, 2025.
Earnings Date | Apr 29, 2025 |
Ex-Dividend Date | Apr 30, 2025 |
Share Statistics
Medicover AB has 150.14 million shares outstanding. The number of shares has increased by 0.35% in one year.
Current Share Class | 73.51M |
Shares Outstanding | 150.14M |
Shares Change (YoY) | +0.35% |
Shares Change (QoQ) | +0.56% |
Owned by Insiders (%) | 11.22% |
Owned by Institutions (%) | 29.44% |
Float | 50.00M |
Valuation Ratios
The trailing PE ratio is 108.93 and the forward PE ratio is 44.67. Medicover AB's PEG ratio is 0.67.
PE Ratio | 108.93 |
Forward PE | 44.67 |
PS Ratio | 1.54 |
PB Ratio | 6.55 |
P/TBV Ratio | n/a |
P/FCF Ratio | 22.49 |
P/OCF Ratio | 12.31 |
PEG Ratio | 0.67 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.31, with an EV/FCF ratio of 30.30.
EV / Earnings | 146.85 |
EV / Sales | 2.07 |
EV / EBITDA | 16.31 |
EV / EBIT | 49.82 |
EV / FCF | 30.30 |
Financial Position
The company has a current ratio of 0.85, with a Debt / Equity ratio of 2.45.
Current Ratio | 0.85 |
Quick Ratio | 0.73 |
Debt / Equity | 2.45 |
Debt / EBITDA | 4.52 |
Debt / FCF | 8.40 |
Interest Coverage | 1.46 |
Financial Efficiency
Return on equity (ROE) is 5.12% and return on invested capital (ROIC) is 3.35%.
Return on Equity (ROE) | 5.12% |
Return on Assets (ROA) | 2.70% |
Return on Invested Capital (ROIC) | 3.35% |
Return on Capital Employed (ROCE) | 5.60% |
Revenue Per Employee | 501,170 |
Profits Per Employee | 7,064 |
Employee Count | 47,256 |
Asset Turnover | 1.04 |
Inventory Turnover | 27.47 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +26.18% in the last 52 weeks. The beta is 1.54, so Medicover AB's price volatility has been higher than the market average.
Beta (5Y) | 1.54 |
52-Week Price Change | +26.18% |
50-Day Moving Average | 210.12 |
200-Day Moving Average | 194.78 |
Relative Strength Index (RSI) | 72.04 |
Average Volume (20 Days) | 87,130 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medicover AB had revenue of SEK 23.56 billion and earned 331.99 million in profits. Earnings per share was 2.21.
Revenue | 23.56B |
Gross Profit | 5.17B |
Operating Income | 978.61M |
Pretax Income | 406.85M |
Net Income | 331.99M |
EBITDA | 2.04B |
EBIT | 978.61M |
Earnings Per Share (EPS) | 2.21 |
Balance Sheet
The company has 1.17 billion in cash and 13.51 billion in debt, giving a net cash position of -12.34 billion or -82.18 per share.
Cash & Cash Equivalents | 1.17B |
Total Debt | 13.51B |
Net Cash | -12.34B |
Net Cash Per Share | -82.18 |
Equity (Book Value) | 5.52B |
Book Value Per Share | 35.24 |
Working Capital | -911.34M |
Cash Flow
In the last 12 months, operating cash flow was 2.94 billion and capital expenditures -1.33 billion, giving a free cash flow of 1.61 billion.
Operating Cash Flow | 2.94B |
Capital Expenditures | -1.33B |
Free Cash Flow | 1.61B |
FCF Per Share | 10.72 |
Margins
Gross margin is 21.94%, with operating and profit margins of 4.15% and 1.41%.
Gross Margin | 21.94% |
Operating Margin | 4.15% |
Pretax Margin | 1.73% |
Profit Margin | 1.41% |
EBITDA Margin | 8.67% |
EBIT Margin | 4.15% |
FCF Margin | 6.83% |
Dividends & Yields
This stock pays an annual dividend of 1.64, which amounts to a dividend yield of 0.68%.
Dividend Per Share | 1.64 |
Dividend Yield | 0.68% |
Dividend Growth (YoY) | 17.10% |
Years of Dividend Growth | 4 |
Payout Ratio | 58.82% |
Buyback Yield | -0.35% |
Shareholder Yield | 0.33% |
Earnings Yield | 0.92% |
FCF Yield | 4.45% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Medicover AB has an Altman Z-Score of 2.04. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.04 |
Piotroski F-Score | n/a |